Stock Screener App

無料 -

インストール

2.305

1.32% 0.025

Aldeyra Therapeutics Inc (ALDX)

概要ニュース株価時系列オプションチェーン Financials ディスカッション予測

Aldeyra Therapeutics Inc (ALDX) 最新ニュース

Levicept Ltd (ALDX) Appoints Darlene Deptula-Hicks as CFO Amid P - GuruFocus

Levicept Appoints Darlene Deptula-Hicks as CFO - GlobeNewswire Inc.

Why Did ALDX Stock Tank 70% Today? - Stocktwits

Spotlight On Aldeyra Therapeutics And 2 Other Prominent Penny Stocks - simplywall.st

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Aldeyra Therapeutics, Inc. (ALDX) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire

Aldeyra Therapeutics, Inc. Actuals & Estimates (TRADEGATE:137) - TradingView

ALDEYRA THERAPEUTICS INC (ALDX) Stock Chart - ChartMill

The Technical Signals Behind (ALDX) That Institutions Follow - Stock Traders Daily

ALDX Stockholders Have Opportunity to Lead Aldeyra Therapeutics - The National Law Review

ALDX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds - The National Law Review

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Aldeyra Therapeutics, Inc. (ALDX) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire

ALDX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announc - The National Law Review

ALDX SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Anno - The National Law Review

Aldeyra Therapeutics, Inc.(NasdaqCM:ALDX) dropped from Russell Small Cap Comp Growth Benchmark - marketscreener.com

Aldeyra Therapeutics, Inc.(NasdaqCM:ALDX) dropped from Russell 2500 Growth Benchmark - marketscreener.com

Aldeyra Therapeutics, Inc.(NasdaqCM: ALDX) dropped from Russell 2000 Value Benchmark - marketscreener.com

Aldeyra Therapeutics, Inc.(NasdaqCM:ALDX) dropped from Russell Microcap Value Benchmark Index - marketscreener.com

Aldeyra Therapeutics, Inc.(NasdaqCM:ALDX) dropped from Russell 2000 Growth Benchmark - marketscreener.com

Aldeyra Therapeutics, Inc.(NasdaqCM: ALDX) dropped from Russell 2000 Dynamic Index - marketscreener.com

Aldeyra Therapeutics, Inc.(NasdaqCM: ALDX) dropped from Russell 3000E Index - marketscreener.com

Aldeyra Therapeutics, Inc.(NasdaqCM:ALDX) dropped from Russell Small Cap Completeness Index - marketscreener.com

Aldeyra Therapeutics, Inc.(NasdaqCM: ALDX) dropped from Russell 3000 Index - marketscreener.com

Aldeyra Therapeutics, Inc.(NasdaqCM: ALDX) dropped from Russell 2000 Index - marketscreener.com

Aldeyra Therapeutics, Inc.(NasdaqCM:ALDX) dropped from Russell 3000E Growth Benchmark - marketscreener.com

Aldeyra Therapeutics, Inc.(NasdaqCM:ALDX) dropped from Russell 3000 Growth Benchmark - marketscreener.com

Aldeyra Therapeutics, Inc. (ALDX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire

137 Forecast — Price Target — Prediction for 2027 - TradingView

Aldeyra Therapeutics, Inc.(NasdaqCM: ALDX) dropped from Russell 2500 Value Benchmark - marketscreener.com

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation int - The National Law Review

Price to book forward of Aldeyra Therapeutics, Inc. – NASDAQ:ALDX - TradingView

Price to book forward of Aldeyra Therapeutics, Inc. – DUS:137 - TradingView

ALDX Forecast — Price Target — Prediction for 2027 - TradingView

Enterprise value to EBITDA forward of Aldeyra Therapeutics, Inc. – NASDAQ:ALDX - TradingView

Enterprise value to EBITDA forward of Aldeyra Therapeutics, Inc. – DUS:137 - TradingView

Enterprise value to revenue forward of Aldeyra Therapeutics, Inc. – NASDAQ:ALDX - TradingView

Enterprise value to revenue forward of Aldeyra Therapeutics, Inc. – DUS:137 - TradingView

Aldeyra Therapeutics, Inc. Actuals & Estimates (NASDAQ:ALDX) - TradingView

Aldeyra appoints Darlene Deptula-Hicks to board of directors By Investing.com - Investing.com Nigeria

Aldeyra Therapeutics, Inc. Actuals & Estimates (DUS:137) - TradingView

Price to earnings forward of Aldeyra Therapeutics, Inc. – NASDAQ:ALDX - TradingView

Price to sales forward of Aldeyra Therapeutics, Inc. – DUS:137 - TradingView

Enterprise value to EBIT forward of Aldeyra Therapeutics, Inc. – NASDAQ:ALDX - TradingView

Price to earnings forward of Aldeyra Therapeutics, Inc. – DUS:137 - TradingView

Bronstein, Gewirtz & Grossman, LLC Is Investigating Aldeyra Therapeutics, Inc. (ALDX) And Encourages Investors to Connect - ACCESS Newswire

Enterprise value to EBIT forward of Aldeyra Therapeutics, Inc. – DUS:137 - TradingView

Aldeyra Therapeutics, Inc. Actuals & Estimates (MUN:137) - TradingView

ALDX Investors Have Opportunity to Lead Aldeyra Therapeutics, Inc - The National Law Review

Aldeyra Therapeutics Inc (ALDX) Valuation: PE, PB & Fair Value Analysis - TradingKey

Aldeyra Therapeutics Inc (ALDX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

Bronstein, Gewirtz & Grossman, LLC Encourages Aldeyra Therapeutics, Inc. (ALDX) Stockholders to Inquire about Securities Investigation - ACCESS Newswire

Precision Trading with Aldeyra Therapeutics Inc. (ALDX) Risk Zones - Stock Traders Daily

2026-06-21 | Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Aldeyra Therapeutics, Inc. (ALDX) and Encourages Investors to Learn More About the Investigation | NDAQ:ALDX | Press Release - Stockhouse

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Aldeyra Therapeutics, Inc. (ALDX) And Encourages Investors to Reach Out - ACCESS Newswire

Aldeyra Therapeutics Inc (ALDX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey

Aldeyra Therapeutics Inc (ALDX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey

Aldeyra Therapeutics Inc (ALDX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

Aldeyra Therapeutics Inc (ALDX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey

Aldeyra Therapeutics Inc (ALDX) Institutional Confidence - TradingKey

Aldeyra Therapeutics Inc (ALDX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey

Aldeyra Therapeutics Inc (ALDX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Aldeyra Therapeutics, Inc. (ALDX) And Encourages Stockholders to Reach Out - ACCESS Newswire

ALDX News | ALDEYRA THERAPEUTICS INC (NASDAQ:ALDX) - ChartMill

Bronstein, Gewirtz & Grossman, LLC Is Investigating Aldeyra Therapeutics, Inc. (ALDX) And Encourages Stockholders to Connect - ACCESS Newswire

Aldeyra Therapeutics (ALDX) grants director options on 73,318 shares - Stock Titan

Aldeyra Therapeutics (ALDX) director receives three new stock option grants - Stock Titan

Aldeyra Therapeutics (ALDX) director receives new stock option awards - Stock Titan

Aldeyra Therapeutics (ALDX) grants board member new stock option awards - Stock Titan

INSM

$113.49

1.16%

ROIV

$35.27

0.23%

RPRX

$57.95

1.95%

ONC

$308.33

0.48%

MRNA

$82.23

0.32%

RVMD

$190.47

0.31%

Yahooで開く | Google で開く | Finviz で開く | マーケットウォッチで開く | エドガーでオープン | ロイターで開く